14 results
DEF 14A
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Apr 21
Definitive proxy
4:46pm
differences in gender, ethnicity, tenure, skills and qualifications. The Compensation and Nominating Committee believes that diversity of backgrounds … Mr. Hull’s tenure, Gen-Probe extended its recognized leadership position in the most rapidly growing diagnostics market segment and the market
PRE 14A
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Apr 21
Preliminary proxy
4:16pm
differences in gender, ethnicity, tenure, skills and qualifications. The Compensation and Nominating Committee believes that diversity of backgrounds … . Hull’s tenure, Gen-Probe extended its recognized leadership position in the most rapidly growing diagnostics market segment and the market
424B4
90afst1 sq1fl
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
rfmqe
25 Mar 21
Draft registration statement
12:00am
424B4
66xe4dd75s6 cv9uson
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
rxuag kovt2p8
29 Oct 20
IPO registration
5:04pm
DRS/A
poqlp4 r9exxhjh
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
jnbn9nwn4h nnptp6
14 Oct 20
Draft registration statement (amended)
12:00am
DRS
qqw5500 4nz6pyf07q2
8 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next